Stay updated on Pembrolizumab and Binimetinib in TNBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Binimetinib in TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Binimetinib in TNBC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site-side version change without changing the displayed study details.
    Difference
    0.1%
    Check dated 2026-04-24T06:11:22.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:38:12.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    Site CMS revision updated to v3.5.0 and previous revision v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-19T05:16:49.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; this appears to be a versioning update rather than a substantive change to study details. No study data, eligibility criteria, or outcomes were altered.
    Difference
    0.1%
    Check dated 2026-03-11T23:44:49.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The site’s previous funding-status notice and an older revision entry (v3.4.1) were removed.
    Difference
    0.4%
    Check dated 2026-02-11T14:10:12.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Added a government funding notice about data currency and NIH operations. Updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:18:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Binimetinib in TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Binimetinib in TNBC Clinical Trial page.